BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31838160)

  • 1. Enteropathic spondyloarthritis: Results from a large nationwide database analysis.
    Picchianti-Diamanti A; Lorenzetti R; Chimenti MS; Luchetti MM; Conigliaro P; Canofari C; Benfaremo D; Bruzzese V; Laganà B; Perricone R;
    Autoimmun Rev; 2020 Feb; 19(2):102457. PubMed ID: 31838160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients.
    Conigliaro P; Chimenti MS; Ascolani M; Triggianese P; Novelli L; Onali S; Lolli E; Calabrese E; Petruzziello C; Pallone F; Perricone R; Biancone L
    Autoimmun Rev; 2016 Feb; 15(2):184-90. PubMed ID: 26554932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and imaging findings in enteropathic spondyloarthritis with special emphasize in diagnostic delay: a cross-sectional study.
    Conigliaro P; D'Antonio A; Wlderk A; Sabuzi F; Ferraioli M; Sichi L; Da Ros V; Biancone L; Bergamini A; Sole Chimenti M
    Ther Adv Chronic Dis; 2024; 15():20406223241229843. PubMed ID: 38380226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach.
    Chimenti MS; Conigliaro P; Triggianese P; Canofari C; Cedola F; Onali S; Calabrese E; Romeo S; Neri B; De Cristofaro E; Biancone L; Perricone R
    Clin Exp Rheumatol; 2019; 37(5):723-730. PubMed ID: 31172920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis.
    Triggianese P; Conigliaro P; Chimenti MS; Biancone L; Monteleone G; Perricone R; Monteleone I
    Clin Exp Rheumatol; 2016; 34(6):1085-1093. PubMed ID: 27782868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis.
    Chimenti MS; Conigliaro P; Polistena B; Triggianese P; D'Antonio A; Neri B; Sena G; Spandonaro F; Biancone L; Perricone R
    Musculoskeletal Care; 2020 Dec; 18(4):527-534. PubMed ID: 32815627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease.
    Olivieri I; Cantini F; Castiglione F; Felice C; Gionchetti P; Orlando A; Salvarani C; Scarpa R; Vecchi M; Armuzzi A
    Autoimmun Rev; 2014 Aug; 13(8):822-30. PubMed ID: 24726868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of spondyloarthritis in Turkish patients with inflammatory bowel disease.
    Beslek A; Onen F; Birlik M; Akarsu M; Akar S; Sari I; Gurler O; Akpinar H; Manisali M; Akkoc N
    Rheumatol Int; 2009 Jun; 29(8):955-7. PubMed ID: 19082597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis.
    Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Rizzello F; Gionchetti P
    J Rheumatol; 2017 Sep; 44(9):1341-1346. PubMed ID: 28412702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated gastroenterology and rheumatology ambulatory: an innovative approach for enteropathic spondyloarthritis early diagnosis.
    Lorenzetti R; Scolieri P; Guarini A; De Marinis F; Zullo A; Hassan C; ; Bruzzese V
    Ann Ist Super Sanita; 2019; 55(3):246-248. PubMed ID: 31553317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study].
    Marín-Jiménez I; García Sánchez V; Gisbert JP; Lázaro Pérez Calle J; Luján M; Gordillo Ábalos J; Tabernero S; Juliá B; Romero C; Cea-Calvo L; García-Vicuña R; Vanaclocha F
    Gastroenterol Hepatol; 2014 Nov; 37(9):495-502. PubMed ID: 24717523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease: A STROBE-compliant study.
    Conigliaro P; Chimenti MS; Triggianese P; D'Antonio A; Sena G; Alfieri N; Biancone L; Perricone R
    Medicine (Baltimore); 2021 Mar; 100(12):e25122. PubMed ID: 33761677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of spondyloarthritis symptom in inflammatory bowel disease patients: A questionnaire survey.
    Kamo K; Shuto T; Haraguchi A
    Mod Rheumatol; 2015 May; 25(3):435-7. PubMed ID: 25381725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease.
    Stolwijk C; Pierik M; Landewé R; Masclee A; van Tubergen A
    Can J Gastroenterol; 2013 Apr; 27(4):199-205. PubMed ID: 23616957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus.
    Macaluso FS; Caprioli F; Benedan L; Bezzio C; Caporali R; Cauli A; Chimenti MS; Ciccia F; D'Angelo S; Fantini MC; Festa S; Iannone F; Lubrano E; Mariani P; Papi C; Provenzano G; Pugliese D; Rispo A; Saibeni S; Salvarani C; Variola A; Zenga M; Armuzzi A; Orlando A; Gerli R
    Autoimmun Rev; 2024 May; 23(5):103533. PubMed ID: 38521214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enteropathic spondylarthritis in chronic inflammatory bowel diseases: prevalence, manifestation pattern and HLA association].
    Protzer U; Duchmann R; Höhler T; Hitzler W; Ewe K; Wanitschke R; Meyer zum Büschenfelde KH; Märker-Hermann E
    Med Klin (Munich); 1996 Jun; 91(6):330-5. PubMed ID: 8767304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of patients with inflammatory bowel disease and spondyloarthritis.
    Pouillon L; Bossuyt P; Vanderstukken J; Moulin D; Netter P; Danese S; Jouzeau JY; Loeuille D; Peyrin-Biroulet L
    Expert Rev Clin Pharmacol; 2017 Dec; 10(12):1363-1374. PubMed ID: 28879780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 associations in inflammatory bowel disease and the enteropathic seronegative spondylarthritis.
    Vounotrypidis P; Kouklakis G; Anagnostopoulos K; Zezos P; Polychronidis A; Maltezos E; Efremidou E; Pitiakoudis M; Lyratzopoulos N
    Auto Immun Highlights; 2013 Dec; 4(3):87-94. PubMed ID: 26000147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of spondyloarthritis in inflammatory bowel disease according ASAS and ultrassonography and its correlation with plasma calprotectin.
    Huber MK; Valim V; Serrano ÉV; Mendonça JA; Lourenço RB; Espírito Santo TMR; Nordal H; de Fátima Bissoli M; de Oliveira Gavi MBR
    Adv Rheumatol; 2024 Apr; 64(1):27. PubMed ID: 38622711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Phosphodiesterase-4 in Psoriatic Arthritis and Inflammatory Bowel Diseases.
    Picchianti-Diamanti A; Spinelli FR; Rosado MM; Conti F; Laganà B
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.